Axsome Therapeutics is trading at $226.25, up +7.17%, primarily driven by global market sentiment after August CPI matched expectations.

  • No clear company-specific announcement or analyst action was identified for September 11, 2026; recent conference commentary was not explicitly linked to the move.
  • The S&P 500, Nasdaq Composite, and Dow Jones are each up roughly 1%.